147 related articles for article (PubMed ID: 24070870)
1. Integrative genome and transcriptome analyses reveal two distinct types of ring chromosome in soft tissue sarcomas.
Nord KH; Macchia G; Tayebwa J; Nilsson J; Vult von Steyern F; Brosjö O; Mandahl N; Mertens F
Hum Mol Genet; 2014 Feb; 23(4):878-88. PubMed ID: 24070870
[TBL] [Abstract][Full Text] [Related]
2. Ring chromosomes and low-grade gene amplification in an atypical lipomatous tumor with minimal nuclear atypia.
Storlazzi CT; Mertens F; Domanski H; Fletcher CD; Wiegant J; Mandahl N
Int J Oncol; 2003 Jul; 23(1):67-71. PubMed ID: 12792777
[TBL] [Abstract][Full Text] [Related]
3. Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays.
Heidenblad M; Hallor KH; Staaf J; Jönsson G; Borg A; Höglund M; Mertens F; Mandahl N
Oncogene; 2006 Nov; 25(53):7106-16. PubMed ID: 16732325
[TBL] [Abstract][Full Text] [Related]
4. MDM2 gene amplification correlates with ring chromosome in soft tissue tumors.
Nilbert M; Rydholm A; Willén H; Mitelman F; Mandahl N
Genes Chromosomes Cancer; 1994 Apr; 9(4):261-5. PubMed ID: 7519048
[TBL] [Abstract][Full Text] [Related]
5. Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas.
Nilsson M; Meza-Zepeda LA; Mertens F; Forus A; Myklebost O; Mandahl N
Int J Cancer; 2004 Apr; 109(3):363-9. PubMed ID: 14961574
[TBL] [Abstract][Full Text] [Related]
6. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
7. Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas.
Zhang W; McElhinny A; Nielsen A; Wang M; Miller M; Singh S; Rueger R; Rubin BP; Wang Z; Tubbs RR; Nagle RB; Roche P; Wu P; Pestic-Dragovich L
Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):54-61. PubMed ID: 20881839
[TBL] [Abstract][Full Text] [Related]
8. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
[TBL] [Abstract][Full Text] [Related]
9. Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling.
Pishas KI; Neuhaus SJ; Clayer MT; Schreiber AW; Lawrence DM; Perugini M; Whitfield RJ; Farshid G; Manavis J; Chryssidis S; Mayo BJ; Haycox RC; Ho K; Brown MP; D'Andrea RJ; Evdokiou A; Thomas DM; Desai J; Callen DF; Neilsen PM
Cancer Res; 2014 Feb; 74(3):921-31. PubMed ID: 24336067
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.
Ito M; Barys L; O'Reilly T; Young S; Gorbatcheva B; Monahan J; Zumstein-Mecker S; Choong PF; Dickinson I; Crowe P; Hemmings C; Desai J; Thomas DM; Lisztwan J
Clin Cancer Res; 2011 Feb; 17(3):416-26. PubMed ID: 21159888
[TBL] [Abstract][Full Text] [Related]
11. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.
Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G
J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978
[TBL] [Abstract][Full Text] [Related]
12. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
14. Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification.
Panagopoulos I; Bjerkehagen B; Gorunova L; Berner JM; Boye K; Heim S
Int J Oncol; 2014 Nov; 45(5):1829-36. PubMed ID: 25176350
[TBL] [Abstract][Full Text] [Related]
15. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma.
Yao J; Pollock RE; Lang A; Tan M; Pisters PW; Goodrich D; El-Naggar A; Yu D
Clin Cancer Res; 1998 Apr; 4(4):1065-70. PubMed ID: 9563903
[TBL] [Abstract][Full Text] [Related]
16. The MDM2 SNP309 G allele is not preferentially amplified in bone and soft tissue tumors.
Mertens F; Brosjö O; von Steyern FV; Nord KH; Mandahl N
Cancer Genet; 2012 Sep; 205(9):470-3. PubMed ID: 22939400
[TBL] [Abstract][Full Text] [Related]
17. Distinct MDM2 and P14ARF expression and centrosome amplification in well-differentiated liposarcomas.
Perucca-Lostanlen D; Rostagno P; Grosgeorge J; Marcié S; Gaudray P; Turc-Carel C
Genes Chromosomes Cancer; 2004 Feb; 39(2):99-109. PubMed ID: 14695989
[TBL] [Abstract][Full Text] [Related]
18. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
Cordon-Cardo C; Latres E; Drobnjak M; Oliva MR; Pollack D; Woodruff JM; Marechal V; Chen J; Brennan MF; Levine AJ
Cancer Res; 1994 Feb; 54(3):794-9. PubMed ID: 8306343
[TBL] [Abstract][Full Text] [Related]
19. HMGA2 and MDM2 expression in lipomatous tumors with partial, low-level amplification of sequences from the long arm of chromosome 12.
Mandahl N; Bartuma H; Magnusson L; Isaksson M; Macchia G; Mertens F
Cancer Genet; 2011 Oct; 204(10):550-6. PubMed ID: 22137485
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages.
Taubert H; Schuster K; Brinck U; Bartel F; Kappler M; Lautenschläger C; Bache M; Trump C; Schmidt H; Holzhausen HJ; Würl P; Schlott T
Mod Pathol; 2003 Nov; 16(11):1109-16. PubMed ID: 14614050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
